Zobrazeno 1 - 10
of 67
pro vyhledávání: '"E. V. Moroz"'
Publikováno v:
Научно-практическая ревматология, Vol 60, Iss 6 (2022)
Gastrointestinal disorders are important place among the visceral manifestations of systemic autoimmune and immunoinflammatory rheumatic diseases (RD). Pathology of the esophagus, stomach, small and large intestine can vary from moderate functional d
Externí odkaz:
https://doaj.org/article/9d2dcc916c344648ad4c1acb23ea03b3
Publikováno v:
Alʹmanah Kliničeskoj Mediciny, Vol 47, Iss 6, Pp 559-567 (2019)
The use of nonsteroidal anti-inflammatory drugs (NSAID), even if short-term, may be associated to small intestinal complications, such as erosions, ulcers and chronic mucosal inflammation. Video capsule endoscopy allows for identification of such les
Externí odkaz:
https://doaj.org/article/005d58b844e34e2dbafff2890c3780b3
Publikováno v:
Неврология, нейропсихиатрия, психосоматика, Vol 11, Iss 4, Pp 100-103 (2019)
Objective: to evaluate the effect of piribedil on cognitive functions in elderly patients with chronic cerebrovascular disease (CCVD) and cognitive impairment (CI). Patients and methods. A total of 67 patients aged 60-75 years with CCVD and CI were e
Externí odkaz:
https://doaj.org/article/592826902b1f4546b11880b3547217eb
Publikováno v:
Acta Biomedica Scientifica, Vol 4, Iss 5, Pp 19-25 (2019)
Intaking antithrombotic funds (ATA) and non-steroidal anti-inflammatory drugs (NSAIDs) is one of the most frequent causes of pathology in gastrointestinal (GI) tract.The purpose of the study: comparison of pathological changes of the mucous membrane
Externí odkaz:
https://doaj.org/article/a9576b4720184c1b9c0641e606234625
Autor:
M. Yu. Fedyanin, Kh. Kh.-M. Elsnukaeva, V. A. Aliev, T. S. Ayrapetyan, A. V. Polyakov, E. V. Moroz, V. A. Uymanov, U. A. Boyarskikh, A. A. Kechin, M. L. Filipenko, S. А. Tjulandin
Publikováno v:
Тазовая хирургия и онкология, Vol 8, Iss 3, Pp 11-16 (2018)
Colon cancer is the 3rd most common malignant neoplasm and the 4th leading cause of mortality from them. The majority of patients are diagnosed at stages II–IV, which indicates the need for markers that can predict disease progression, especially a
Externí odkaz:
https://doaj.org/article/ab372d1968ee42b2bc22fe2a90273fb0
Publikováno v:
Общая реаниматология, Vol 14, Iss 3, Pp 15-26 (2018)
Use of antithrombotic aids (ATA) significantly impact the prevention of life-threatening cardiovascular complications. ATA applications, however, are associated with a wide range of adverse digestive system responses. Due to, continuously growing cli
Externí odkaz:
https://doaj.org/article/8f31965b50934e079f67b5344c387bbe
Autor:
E. V. Moroz
Publikováno v:
Вестник Кемеровского государственного университета, Vol 0, Iss 1, Pp 66-73 (2018)
The purpose of this article is to analyze the reasons and the substantive content of the critical discourse on totalitarianism developed in foreign historiography of the 1960s. The analysis is based on the fundamental methodological principles of his
Externí odkaz:
https://doaj.org/article/1c3412e0f2e743a2b82e607a64b15636
Publikováno v:
Научно-практическая ревматология, Vol 55, Iss 6, Pp 675-684 (2018)
Novel oral anticoagulants (NOACs), such as the direct thrombin inhibitor dabigatran and the selective factor Xa inhibitors rivaroxaban and apixaban, are increasingly used as an effective antithrombotic drug in real clinical practice. Unfortunately, t
Externí odkaz:
https://doaj.org/article/8ed0dae84c494584b6c16551dfe094a5
Autor:
E. V. Moroz, A. E. Karateev
Publikováno v:
Современная ревматология, Vol 10, Iss 4, Pp 97-105 (2016)
Prevention of gastrointestinal tract (GIT) complications is the most important element for the rational use of nonsteroidal anti-inflammatory drugs (NSAIDs) and low-dose aspirin (LDA). Proton pump inhibitors (PPIs) have long been the only medication
Externí odkaz:
https://doaj.org/article/1cea8077e0c646a1b2d60409a13098a4
Autor:
V. A. Sulimov, E. V. Moroz
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 8, Iss 1, Pp 23-30 (2015)
Aim. To study prevalence of resistance to acetylsalicylic acid, clopidogrel and dual resistance in percutaneous coronary intervention (PCI), to identify clinical risk factors of resistance development, to study effects of concomitant therapy on resis
Externí odkaz:
https://doaj.org/article/c4ce5929be554a8f99733bcc1e447617